在患有多囊性卵巢综合征的妇女中,胰岛素抵抗指数和肝功能参数之间的关联
Marzieh Saei Ghare Naz1, Maryam Mousavi1, Faezeh Firouzi2
1Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Endocrinology, diabetes & metabolism
|May 21, 2024
概括
胰岛素耐药性指数,如TG/HDL-C和甘油三糖 (TyG),可能有助于检测女性的肝功能异常. 多囊性卵巢综合征 (PCOS) 状态并没有改变胰岛素抵抗和肝脏功能障碍之间的这种关联.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 多囊卵巢综合征 (PCOS) 是一种常见的内分泌疾病,与代谢并发症有关.
- 胰岛素抵抗 (IR) 是PCOS的一个关键特征,与肝脏功能障碍有关.
- PCOS状态在改变IR和肝功能参数之间的关系中的作用需要进一步研究.
研究的目的:
- 为了检查多囊性卵巢综合征 (PCOS) 状态是否影响女性胰岛素抵抗 (IR) 指数和肝功能参数之间的关联.
- 评估TG/HDL-C和甘油三糖 (TyG) 指数在检测肝功能异常方面的有用性.
主要方法:
- 来自德黑兰脂质和葡萄糖研究 (TLGS) 的1101名年龄≥20岁的妇女的横截面,基于人群的研究.
- 评估PCOS状态,IR指数 (TG/HDL-C,TyG) 和肝功能参数 (HSI,ALT,AST) 的情况.
- 统计分析以确定因年龄和BMI而调整的关联.
主要成果:
- 在PCOS和非PCOS组之间,肝功能异常没有显著差异.
- TyG指数较高的三位数与AST,ALT和HSI的升高有关.
- 高TG/HDL-C的高分位与ALT和HSI的升高有关,第二分位和ALT有显著的关联.
- PCOS状态并没有显著改变IR指数和肝功能测试升高之间的关联.
结论:
- 胰岛素抵抗指数,特别是甘油三-葡萄糖 (TyG) 指数和TG/HDL-C比率,可以作为检测女性肝功能异常的有价值替代品.
- 多囊卵巢综合征 (PCOS) 状态似乎不会改变胰岛素抵抗和肝脏功能障碍之间的关系.
相关概念视频
02:07Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192